SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-17-045410
Filing Date
2017-08-28
Accepted
2017-08-28 17:01:45
Documents
3
Period of Report
2017-08-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A v474100_pre14a.htm PRE 14A 930791
2 GRAPHIC proxy1.jpg GRAPHIC 298731
3 GRAPHIC proxy2.jpg GRAPHIC 171107
  Complete submission text file 0001144204-17-045410.txt   1579350
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35112 | Film No.: 171055199
SIC: 2836 Biological Products, (No Diagnostic Substances)